Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Sell
9,956
-204
-2% -$23.9K 0.28% 61
2026
Q1
$1.22M Sell
10,160
-22
-0.2% -$2.54K 0.3% 58
2025
Q4
$1.07M Sell
10,182
-730
-7% -$68.5K 0.25% 62
2025
Q3
$916K Sell
10,912
-112
-1% -$9.22K 0.22% 65
2025
Q2
$873K Sell
11,024
-130
-1% -$10.3K 0.23% 65
2025
Q1
$1M Sell
11,154
-661
-6% -$61.7K 0.29% 59
2024
Q4
$1.18M Sell
11,815
-128
-1% -$13.2K 0.32% 52
2024
Q3
$1.36M Sell
11,943
-1,383
-10% -$164K 0.38% 52
2024
Q2
$1.65M Sell
13,326
-333
-2% -$42.9K 0.51% 45
2024
Q1
$1.8M Sell
13,659
-3,272
-19% -$403K 0.57% 42
2023
Q4
$1.85M Sell
16,931
-498
-3% -$51.7K 0.65% 38
2023
Q3
$1.79M Buy
17,429
+644
+4% +$69.4K 0.71% 37
2023
Q2
$1.94M Sell
16,785
-62
-0.4% -$7.04K 0.75% 36
2023
Q1
$1.79M Buy
16,847
+1,240
+8% +$134K 0.76% 33
2022
Q4
$1.73M Sell
15,607
-275
-2% -$28.1K 0.82% 27
2022
Q3
$1.37M Sell
15,882
-546
-3% -$48.7K 0.71% 35
2022
Q2
$1.5M Sell
16,428
-751
-4% -$66.6K 0.75% 34
2022
Q1
$1.41M Buy
+17,179
New +$1.35M 0.57% 43
2021
Q4
Sell
-16,857
Closed -$1.27M 89
2021
Q3
$1.27M Buy
16,857
+749
+5% +$57K 0.55% 41
2021
Q2
$1.25M Sell
16,108
-667
-4% -$49.6K 0.55% 42
2021
Q1
$1.23M Sell
16,775
-67
-0.4% -$4.94K 0.58% 40
2020
Q4
$1.31M Sell
16,842
-2,723
-14% -$208K 0.65% 39
2020
Q3
$1.55M Buy
19,565
+1,205
+7% +$94.4K 0.87% 29
2020
Q2
$1.35M Buy
18,360
+5,264
+40% +$396K 0.82% 32
2020
Q1
$961K Buy
13,096
+44
+0.3% +$3.46K 0.73% 40
2019
Q4
$1.13M Sell
13,052
-5,639
-30% -$463K 0.68% 43
2019
Q3
$1.5M Buy
18,691
+2,908
+18% +$233K 1.04% 23
2019
Q2
$1.26M Hold
15,783
0.89% 30
2019
Q1
$1.25M Buy
15,783
+7,159
+83% +$535K 0.95% 25
2018
Q4
$629K Sell
8,624
-567
-6% -$40K 0.56% 46
2018
Q3
$622K Buy
9,191
+2,799
+44% +$178K 0.47% 47
2018
Q2
$370K Sell
6,392
-375
-6% -$21.2K 0.29% 66
2018
Q1
$352K Buy
+6,767
New +$365K 0.29% 66

Other funds holding MRK

DeDora Capital's MRK Position: Q2 2026 in Review

DeDora Capital reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $23.9K and leaving 9,956 shares worth $1.28M. The position accounts for 0.28% of the portfolio, ranked #61.

DeDora Capital first reported a position in MRK in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.94M in Q2 2023. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • DeDora Capital held 9,956 shares of Merck worth $1.28M as of Q2 2026.
  • DeDora Capital sold 204 Merck shares in Q2 2026, an estimated $23.9K.
  • Merck made up 0.28% of DeDora Capital's portfolio in Q2 2026, its #61 holding.
  • DeDora Capital first reported a position in Merck in Q1 2018 and has held it in 33 quarters since.
  • DeDora Capital's Merck position peaked at $1.94M in Q2 2023.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DeDora Capital's 13F filing for Q2 2026, filed 13 Jul 2026.